Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure

Molecular Carcinogenesis

Volumn 50, Issue 2, 2011, Pages 89-99

  Ali, Abdellah H K ^a,b   Kondo, Kazuya ^b   Namura, Toshiaki ^b   Senba, Yoshitaka ^b   Takizawa, Hiromitsu ^b   Nakagawa, Yasushi ^b   Toba, Hiroaki ^b   Kenzaki, Koichiro ^b   Sakiyama, Shoji ^b   Tangoku, Akira ^b  

^a Sohag University   (Egypt)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Carcinogenesis; Chromate lung cancer; Chromium; Methylation; Methylation specific PCR

Indexed keywords

CHROMIC ACID; PROTEIN P16;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DNA METHYLATION; DRUG EXPOSURE; EPIGENETICS; HUMAN; LUNG CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CHROMATES; CPG ISLANDS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; EPIGENESIS, GENETIC; GENES, APC; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NUCLEAR PROTEINS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 78651465618     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20697     Document Type: Article

References (43)

1. Zhitkovich A. Chromium: Exposure, toxicity and biomonitoring approaches. In: Wilson SH, Suk WA, editors. Biomarkers of environmentally associated disease: Technologies, concepts, and perspectives. New York: CRC Press LLC; 2002. pp. 269-287.
2. Occupational Safety and Health Administration (OSHA). Department of Labor. Occupational exposure to hexavalent chromium. Final rule Fed Regist 2006; 71: 10099-10385.
3. Gibb HJ, Lees PS, Pinsky PF, Rooney BC. Lung cancer among workers in chromium chemical production. Am J Ind Med 2000; 38: 115-126.
4. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: Nickel, arsenic and chromium. Chem Res Toxicol 2008; 21: 28-44.
5. Kondo K, Hino N, Sasa M, et al. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem Biophy Res Commun 1997; 239: 95-100.
6. Ewis AA, Kondo K, Lee J, et al. Occupational cancer genetics: Infrequent ras oncogenes point mutation in lung cancer samples from chromate workers. Am J Ind Med 2001; 40: 92-97.
7. Hirose T, Kondo K, Takahashi Y, et al. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol Carcinog 2002; 33: 172-180.
8. Takahashi Y, Kondo K, Hirose T, et al. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol Carinog 2005; 42: 150-158.
9. Peterson-Roth E, Reynolds M, Quievryn G, Zhitkovich A. Mismatch repair proteins are activators of toxic responses to chromium-DNA damage. Mol Cell Biol 2005; 25: 3596-3607.
10. Reynolds M, Zhitkovich A. Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53. Carcinogenesis 2007; 28: 1613-1620.
11. Kondo K, Takahashi Y, Hirose Y, et al. The reduced expression and aberrant methylation of p16INK4a in chromate workers with lung cancer. Lung Cancer 2006; 53: 295-302.
12. Klein CB, Su L, Bowser D, Leszczynska J. Chromate-induced epimutations in mammalian cells. Environ Health Perspect 2002; 110: 739-743.
13. Labra M, Grassi F, Imazio S, et al. Genetic and DNA-methylation changes induced by potassium dichromate in Brassica napus L. Chemosphere 2004; 54: 1049-1058.
14. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
15. Toyooka S, Toyooka KO, Maruyama R, et al. DNA methylation profiles of lung tumors. Mol Cancer Ther 2001; 1: 61-67.
16. Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001; 61: 249-255.
17. Zochbauer-Muller S, Minna JD, Gazdar AF. Aberrant DNA methylation in lung cancer: Biological and clinical implications. Oncologist 2002; 7: 451-457.
18. Safar AM, Spencer H, Su X, et al. Methylation profiling of archived non-small cell lung cancer: A promising prognostic system. Clin Cancer Res 2005; 11: 4400-4405.
19. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003; 4: 351-358.
20. 6-methylguanine-DNA methyltransferase gene. Cancer Res 1997; 57: 3672-3677.
21. Deng G, Chen A, Hong J, Chae HS, Kim YS. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 1999; 59: 2029-2033.
22. Esteller M, Sparks A, Toyota M, et al. Analysis of Adenomatous Polyposis Coli promoter hypermethylation in human cancer. Cancer Res 2000; 60: 4366-4371.
23. Tsuchiya T, Tamura G, Sato K, et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000; 19: 3642-3646.
24. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
25. House MG, Guo M, Iacobuzio-Donahue C, Herman JG. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 2003; 24: 193-198.
26. Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K. Aberrant p16 promoter methylation in smokers and former smokers with no small cell lung cancer. Int J Cancer 2003; 106: 913-918.
27. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003; 94: 589-592.
28. Lin Q, Geng J, Ma K, et al. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. J Cancer Res Clin Oncol 2009; 135: 1675-1684.
29. Topaloglu O, Hoque MO, Tokumaru Y, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004; 10: 2284-2288.
30. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-3229.
31. Sun H, Zhou X, Chen H, Li Q, Costa M. Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol Appl Pharmacol 2009; 237: 258-266.
32. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4: 988-993.
33. Yamamoto H, Min Y, Itoh F, et al. Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability. Genes Chromosomes Cancer 2002; 33: 322-325.
34. Li Q, Jedlicka A, Ahuja N, et al. Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene 1998; 16: 3197-3202.
35. Shen L, Ahuja N, Shen Y, et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002; 94: 755-761.
36. Strathdee G, Appleton K, Illand M, et al. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol 2001; 158: 1121-1127.
37. Lind GE, Thorstensen L, Lovig T, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004; 3: 28.
38. Bienz M. The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 2002; 3: 328-338.
39. Fodde R, Kuipers J, Rosenberg C, et al. Mutations in the APC tumor suppressor gene cause chromosomal instability. Nat Cell Biol 2001; 3: 433-438.
40. Dikovskaya D, Newton IP, Näthke IS. The adenomatous polyposis coli protein is required for the formation of robust spindles formed in CSF Xenopus extracts. Mol Biol Cell 2004; 15: 2978-2991.
41. Holmes AL, Wise SS, Pelsue SC, et al. Chronic exposure to zinc chromate induces centrosome amplification and spindle assembly checkpoint bypass in human lung fibroblasts. Chem Res Toxicol 2010; 23: 386-395.
42. Kang GH, Lee S, Kim WH, et al. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002; 160: 787-794.
43. Kim DH, Nelson HH, Wiencke JK, et al. p16 (INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61: 3419-3424.